It sounds like we are starting to get some action on this. Five years ago, Congress passed Dodd-Frank...
Elizabeth Warren
The Public Record
Elizabeth Ann Warren is an American attorney, academic, and politician serving as the senior United States senator from Massachusetts since 2013. A member of the Democratic Party, she has been a prominent advocate for consumer protection, economic equality, and corporate regulation. Warren gained national recognition for her work in establishing the Consumer Financial Protection Bureau and has focused on issues such as student debt relief and healthcare reform during her tenure in the Senate.
These pension scam companies turn a profit by offering retirees cash in exchange for a fixed amount of the buyer's future pension.
These loans can have pretty shocking fine print, for example, effective interest rates over 100 percent.
Thank you, Chair Collins. I want to thank you for holding this hearing today. This is really important.
I hope that everyone on this Committee will support him and that he gets an up-or-down vote from the Senate very quickly.
Or we can play it safe, keep the threshold where it is, and rely on the Fed to follow the law and tailor the risks--tailor the regulations to the risks that are posed by different large financial institutions.
To me, this is an easy decision. We can raise the threshold and cut loose half or more of the biggest banks in the country and just hope they do not make the same mistakes that they made in 2008 when they nearly brought down the whole…
Wale is a miracle worker. He works hard. He is smart. He manages people and projects with amazing skill.
This tougher scrutiny is designed to focus the attention of the regulators on where the risk is.
I will be honest. I am deep-down furious at the Republican scheme to defund Planned Parenthood. I didn't think the Republican leadership could sink any lower than trying to defund women's cancer screenings and access to birth control, but…
We've got to have those. I get that you want to get those. We also need a plan in place that's going to educate physicians, that's going to educate the public because there really will be confidence that this work.
I'm concerned that misunderstandings about biosimilars could hamper their uptake in the market.
I want to know if you will commit to working with me to make sure that both the regulators and the financial industry are doing everything possible to shut down financing for human trafficking.
a better path forward is to accept this agreement and maintain unity with our international partners.
I have legislation to ensure that the Treasury Department and other financial regulators work more closely with financial institutions to stop human traffickers' use of the banking system.
The real question that I'm pushing on is that it is time now to get this done.
If we walk away from this deal, is it more likely or is it less likely that our international partners will continue tough sanctions?
We know from the very established generic drug market that it suffers from severe misperceptions here.
If we back out of this deal, the international coalition that has made sanctions so effective would fracture.
Biologic drugs, complex products like enzymes and antibodies, are great medical achievements that allow people to live longer, healthier lives.
Making sure that patients have access to their own information is also the best way to engage patients in their own healthcare and to improve outcomes.





